Pharmacy

Here are five articles recently published by Becker's Hospital Review that offer insights on hospital drug spending, new pricing models and more.

President Donald Trump's former personal attorney Michael Cohen tesified Feb. 27 about why drug giant Novartis paid him $1.2 million, reigniting a headache for Novartis, according to STAT.

When seven pharma executives testified before the Senate Finance Committee this week to answer questions about their industry's drug-pricing practices, they pledged to work with lawmakers to keep costs down, but offered no solid commitments — an unacceptable response in…

Private equity firm Blackstone Life Sciences has partnered with Swiss drugmaker Novartis to launch a company to develop a heart drug, according to The Wall Street Journal.

There are now 8,774 urgent care centers in the U.S., a number that has the potential to grow as such companies as CVS Health and Walgreens ramp up their healthcare offerings, according to a Forbes report.

A pharmacy professor from the University of Missouri-Kansas City stole a student's research and secretly sold it to a pharmaceutical company for $1.5 million, a lawsuit filed Feb. 26 charges.

Amazon selected Nader Kabbani, a 14-year company veteran, to run its new pharmacy business, CNBC reports.

Firdapse, a formerly inexpensive drug that treats a rare autoimmune disorder, received a new annual $375,000 price tag in December, prompting one patient to begin rationing the medication that enables her to walk, according to a CNN report.

Seven pharmaceutical executives, representing $140 billion in U.S. revenue, testified before the Senate Finance Committee Feb. 26.

Like the rest of healthcare, the practice of hospital pharmacy has undergone dramatic change over the past half century. Today, hospital executives rely on the pharmacy as a strategic partner and a vital part of the patient care team.